Elke Hunsche

ORCID: 0000-0002-5611-0554 · 6 papers in corpus · active 2018-2025

Study types

  • article 5
  • rct 1

Condition tags

  • endometriosis 6
  • dyspareunia 3
  • dysmenorrhea 2
  • mesh:D004715 2
  • mesh:D017699 2
  • mesh:D004412 1
article 2025
Attribute preferences associated with gonadotropin-releasing hormone agonists/antagonists among women with endometriosis in the United States
Women's health (London, England) ·doi:10.1177/17455057251331700

BACKGROUND: Endometriosis symptoms have multifaceted manifestations, and there are few approved nonsurgical treatment options. Gonadotropin-releasing hormone (GnRH) agonists/antagonists for endometriosis vary on efficacy, safety profile, an…

rct 2024
Impact of relugolix combination therapy on functioning and quality of life in women with endometriosis-associated pain
Fertility and sterility ·doi:10.1016/j.fertnstert.2024.06.009

OBJECTIVE: To evaluate the effect of relugolix combination therapy (relugolix CT; 40 mg relugolix, 1 mg estradiol, and 0.5 mg norethisterone acetate) for up to 2 years in the SPIRIT long-term extension study on functioning and health-relate…

article 2023
Endometriosis Symptoms and Their Impacts on the Daily Lives of US Women: Results from an Interview Study
International journal of women's health ·doi:10.2147/ijwh.s409733

Objective: This interview study sought to capture patients' experiences and perceptions of endometriosis symptoms and their impacts on daily life, as described by women in their own words. Using open-ended questions and a concept-elicitatio…

article 2022
SUSTAINED IMPROVEMENT IN PHYSICAL FUNCTION AND QUALITY OF LIFE IN WOMEN WITH ENDOMETRIOSIS-ASSOCIATED PAIN TREATED WITH RELUGOLIX COMBINATION THERAPY OVER 104 WEEKS: SPIRIT LONG-TERM EXTENSION STUDY
·doi:10.1016/j.fertnstert.2022.08.020
article 2021
RELUGOLIX COMBINATION THERAPY IMPROVES MULTIPLE DIMENSIONS OF QUALITY OF LIFE IN WOMEN WITH ENDOMETRIOSIS-ASSOCIATED PAIN: RESULTS FROM THE SPIRIT PROGRAM
·doi:10.1016/j.fertnstert.2021.07.146
article 2018
PIH15 - PREVALENCE OF DIAGNOSED UTERINE FIBROIDS AND ENDOMETRIOSIS IN THE US: DATA FROM A NATIONALLY REPRESENTATIVE POPULATION-BASED SURVEY
·doi:10.1016/j.jval.2018.09.1280